CAS
ACAD icon

Coppell Advisory Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History

Coppell Advisory Solutions’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4
Closed -$67 – 341
2024
Q4 		$67 Hold
4
– – ﹤0.01% 1921
2024
Q3 		$63 Hold
4
– – ﹤0.01% 1825
2024
Q2 		$65 Buy
+4
New +$65 ﹤0.01% 1745
2023
Q4 		$29K Buy
925
+625
+208% +$14.9K 0.01% 635
2023
Q3 		$4.78K Hold
300
– – ﹤0.01% 721
2023
Q2 		$7.2K Buy
+300
New +$6.67K ﹤0.01% 766
2023
Q1 		– Sell
-600
Closed -$9.55K – 207
2022
Q4 		$9.55K Buy
+600
New +$9.38K ﹤0.01% 620

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return